BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190911T160000
DTEND;TZID=Europe/London:20190911T180000
DTSTAMP:20260410T121337
CREATED:20190806T071217Z
LAST-MODIFIED:20190806T071217Z
UID:18004-1568217600-1568224800@staging.medilinkmidlands.com
SUMMARY:Webinar: How do I make the transition from candidate selection through to proof-of-concept?
DESCRIPTION:Join Nikki Whitfield\, VP\, CDMO Services at Quotient Sciences and Claire Thompson\, CEO\, Agility Health Tech and discover how to transition from your candidate selection process and how to utilize a data driven approach to develop the right dosage forms to achieve proof-of-concept. \nThis webinar will explore screening techniques\, integrated approaches and phase-appropriate development strategies. \nLearning Points:\n• What is a suitable screening package for determining the physical properties of an API and what are the red-flags to watch out for?\n• How can the developability classification system (DCS) be used to streamline my formulation development program?\n• How will in-vitro testing and pre-clinical evaluation help me guide the clinical formulation?\n• Will a pre-clinical formulation be suitable for clinical use?\n• Could a simple pharmacy preparation be suitable for my FIH trial or will a manufactured dosage form be required?\n• How can we bridge from pharmacy preparations to GMP solid oral dosage forms that will be robust and scalable?\n• How can you avoid common development pitfalls and ensure future success? \nTo register please click here. \nwww.quotientsciences.com
URL:https://staging.medilinkmidlands.com/event/webinar-how-do-i-make-the-transition-from-candidate-selection-through-to-proof-of-concept/
CATEGORIES:Medilink Partner Event
END:VEVENT
END:VCALENDAR